Duration
6 months
Cost
Free to Patients
Phase
Phase IV
Closes
Nov 2025
Assessing whether continuous glucose monitoring improves outcomes and reduces hypoglycemia in elderly T2D patients.
Check your eligibility in under 2 minutes. No commitment required β a coordinator will guide you through next steps.
Check My Eligibility βFree to apply Β· No medical records needed to start
Trial Summary
National Institute of Diabetes
Comparing a structured low-carbohydrate eating plan to standard dietary guidelines for blood sugar management.
NCT05634892
Eli Lilly UAE
Head-to-head comparison of tirzepatide and insulin glargine in UAE adults with poorly controlled T2D.
NCT05401245